Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

269 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues.
Nebert DW, Ingelman-Sundberg M, Daly AK. Nebert DW, et al. Among authors: daly ak. Drug Metab Rev. 1999 May;31(2):467-87. doi: 10.1081/dmr-100101931. Drug Metab Rev. 1999. PMID: 10335448 Review.
Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County.
London SJ, Sullivan-Klose T, Daly AK, Idle JR. London SJ, et al. Among authors: daly ak. Pharmacogenetics. 1997 Oct;7(5):401-4. doi: 10.1097/00008571-199710000-00010. Pharmacogenetics. 1997. PMID: 9352577 No abstract available.
Nomenclature for human CYP2D6 alleles.
Daly AK, Brockmöller J, Broly F, Eichelbaum M, Evans WE, Gonzalez FJ, Huang JD, Idle JR, Ingelman-Sundberg M, Ishizaki T, Jacqz-Aigrain E, Meyer UA, Nebert DW, Steen VM, Wolf CR, Zanger UM. Daly AK, et al. Pharmacogenetics. 1996 Jun;6(3):193-201. doi: 10.1097/00008571-199606000-00001. Pharmacogenetics. 1996. PMID: 8807658
Human cytochrome P450 (CYP) genes: recommendations for the nomenclature of alleles.
Ingelman-Sundberg M, Daly AK, Oscarson M, Nebert DW. Ingelman-Sundberg M, et al. Among authors: daly ak. Pharmacogenetics. 2000 Feb;10(1):91-3. doi: 10.1097/00008571-200002000-00012. Pharmacogenetics. 2000. PMID: 10739177 No abstract available.
Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism.
London SJ, Daly AK, Fairbrother KS, Holmes C, Carpenter CL, Navidi WC, Idle JR. London SJ, et al. Among authors: daly ak. Cancer Res. 1995 Dec 15;55(24):6035-7. Cancer Res. 1995. PMID: 8521388
CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan.
Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, Reed CD, Chen IH, Caporaso NE, Hsu MM, Chen JY, Idle JR, Hoover RN, Yang CS, Chhabra SK. Hildesheim A, et al. Among authors: daly ak. J Natl Cancer Inst. 1997 Aug 20;89(16):1207-12. doi: 10.1093/jnci/89.16.1207. J Natl Cancer Inst. 1997. PMID: 9274915
HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury.
Nicoletti P, Werk AN, Sawle A, Shen Y, Urban TJ, Coulthard SA, Bjornsson ES, Cascorbi I, Floratos A, Stammschulte T, Gundert-Remy U, Nelson MR, Aithal GP, Daly AK; International Drug-induced Liver Injury Consortium. Nicoletti P, et al. Among authors: daly ak. Pharmacogenet Genomics. 2016 May;26(5):218-24. doi: 10.1097/FPC.0000000000000209. Pharmacogenet Genomics. 2016. PMID: 26959717
Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County.
London SJ, Smart J, Daly AK. London SJ, et al. Among authors: daly ak. Lung Cancer. 2000 May;28(2):147-55. doi: 10.1016/s0169-5002(99)00130-0. Lung Cancer. 2000. PMID: 10717332
Ultrarapid metabolizers of debrisoquine: characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene.
Løvlie R, Daly AK, Molven A, Idle JR, Steen VM. Løvlie R, et al. Among authors: daly ak. FEBS Lett. 1996 Aug 19;392(1):30-4. doi: 10.1016/0014-5793(96)00779-x. FEBS Lett. 1996. PMID: 8769309
CYP2D6 allelic frequencies in young-onset Parkinson's disease.
Sandy MS, Armstrong M, Tanner CM, Daly AK, Di Monte DA, Langston JW, Idle JR. Sandy MS, et al. Among authors: daly ak. Neurology. 1996 Jul;47(1):225-30. doi: 10.1212/wnl.47.1.225. Neurology. 1996. PMID: 8710083
269 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback